The Long-Term Prognosis of Residual Tinnitus with Idiopathic Sudden Sensorineural Hearing Loss

Has anyone seen this research? Looks like it came out in August 2020. If I'm reading this correctly, they seem to be suggesting the median time for tinnitus recovery after SSHL is 24 months. Gives me hope!

The Long-term Prognosis of Residual Tinnitus with Idiopathic Sudden Sensorineural Hearing Loss

Objectives:
To analyze the factors affecting the long-term prognosis of tinnitus accompanied with unilateral idiopathic sudden sensorineural hearing loss (SSNHL).

Design:
A cohort study.

Setting:
Academic hospital.

Participants:
A total of 161 patients with sudden hearing loss accompanied by tinnitus were enrolled. All the patients had two separate telephone follow-ups and were asked about changes in tinnitus.

Main outcome measures
The severity of tinnitus at admission and the outcome at discharge were assessed in terms of the patients’ sex, age, level of hearing loss, type of audiogram, and so on.

Results and Conclusions
Initial tinnitus level was remarkably associated with tinnitus efficacy at discharge and was an independent risk factor for the long-term prognosis of residual tinnitus after SSNHL (odds ratio 0.722, 95% confidence interval 0.550-0.949, p = 0.019), and the median recovery time was 23.00 ± 3.80

 

Same here! Just one year in! How about you?

 

Thanks for sharing, this gives me some hope.

 

I'm no expert but I'm not sure how I can rate this paper.

They interviewed tinnitus patients who experienced SSHL three times and out of these interviews they conclude that tinnitus will recover, on average, after 2 years.

How did these people recover? Is it subjective (they habituated)? Did the tinnitus heal on its own or did these people undergo treatment?

It seems to still be a pre-print. This means that other researchers have not peer-reviewed it yet (for quality, among other things).

 

Well, when they talk about the gatekeeping interface of the brain, the assumption is that it needs time to adapt to the new "bad data".

 

This is the treatment all of these patients received:

All patients received 40 mg of intravenous methylprednisolone for 5 consecutive days and hemodilution agents for 10 days, including 87.5 mg of intravenous EGb-761 (Dr. Willmar Schwabe GmbH & Co., Germany) every day and 5 BU of intravenous batroxobin (Beijing Tobishi Pharmaceutical Co.), the first dose was doubled, and every other day based on fibrinogen levels.​

I'm not sure how that compares to treatments any of us have received. I'm taking Prednisone right now but none of these other things.